89bio Announces Presentations of BIO89-100 Data at The Liver Meeting® 2019
11 nov. 2019 09h25 HE
|
89bio, Inc.
SAN FRANCISCO and HERZLIYA, Israel, Nov. 11, 2019 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company, announced that two posters related to its...
89bio Announces Pricing of Upsized Initial Public Offering
11 nov. 2019 08h22 HE
|
89bio, Inc.
SAN FRANCISCO and HERZLIYA, Israel, Nov. 11, 2019 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of...